Sign inJoin free

Watch / Stock Selection

Ben sees these small caps shining

16 Sept 20257:32

Ben sees these small caps shining

General information only. ausbiz videos are general information only, produced by Ausbiz TV Pty Ltd, a media business that doesn’t give financial advice. They don’t take into account your objectives, financial situation or needs. Consider whether it’s right for you and read the PDS and TMD before acting on anything you watch.

About this video

Key points:

  • Emeco (ASX:EHL) seen as best risk-reward in small caps, trading well below NTA

  • Eroad (ASX:ERD) completes transition to profitability with strong recurring revenue

  • XRF Scientific (ASX:XRF) posts 15% profit growth despite flat revenue, boasting market leadership

  • Positive small cap outlook driven by takeover interest and latent portfolio value

Ben Richards from Seneca Financial Solutions notes increased interest and activity in the small cap sector, highlighting takeovers as a major theme. Richards identifies Emeco (ASX:EHL) as a standout opportunity, suggesting it offers the best risk-reward profile currently. He points out that Amoco has been trading significantly below its net tangible asset (NTA) value, with the potential for a substantial re-rating, especially with strategic interest circulating and robust free cash flow projections. According to Richards, Amoco’s diversified asset base and dominant position in heavy machinery make it an appealing target, particularly if major shareholder Black Diamond pursues an exit via takeover.

Turning to Eroad (ASX:ERD), Richards describes the business as having flown under the radar until recent profitability milestones triggered a 40% return over the last year. Eroad’s focus on fleet telematics and transport analytics, especially in New Zealand, positions it well as it completes a significant CapEx upgrade from 3G to 4G devices. Richards suggests these improvements, coupled with its recurring revenue and market share expansion, could see Eroad re-rate upwards with growth peaking in FY26.

Richards also mentions XRF Scientific (ASX: XRF), pointing out its resilient profit growth and dominant market share in lab consumables and testing equipment. He expresses confidence in further upside on the back of accelerating sample volumes and underinvestment in mining capital expenditure.

More like this

We value your privacy

We use essential cookies to make the site work. Non-essential cookies help us improve the experience. You can accept or reject non-essential cookies. Privacy policy